Targeting RNA m(6)A marks in apoptosis-related transcripts holds promise for RNA therapeutics. However, pathway-specific RNA m(6)A sites on pro- or antiapoptotic transcripts have not been fully unveiled, let alone characterized. This article summarizes the current knowledge and gaps in the cellular response modulated by apoptotic stimulus-specific RNA m(6)A marks.
